Skip to main content
Clinical Trials/CTIS2024-510766-16-00
CTIS2024-510766-16-00
Active, not recruiting
Phase 1

(SPARROW) Standard versus Pre-emptive Antibiotic Treatment to Reduce the Rate of Infectious Outcomes after Whipple’s procedure (SPARROW): a multicenter, randomized controlled trial - NL82304.058.22

Academisch Ziekenhuis Leiden0 sites344 target enrollmentJune 5, 2024

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Pancreatoduodenectomy with a high risk for contaminated bile
Sponsor
Academisch Ziekenhuis Leiden
Enrollment
344
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 5, 2024
End Date
TBD
Last Updated
last year
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients undergoing elective pancreatoduodenectomy with a high risk for contaminated bile defined as patients with preoperative biliary drainage or an ampullary malignancy., Age \>18 years

Exclusion Criteria

  • Pregnancy, Contraindication for the study antibiotics (e.g. allergy or intolerance), Indication for endocarditis prophylaxis, Preoperative planned therapeutic antibiotic treatment after surgery (i.e. for cholangitis or liver abscesses), A reduced renal function, defined as a eGFR of \<60 ml/min/1\.73m2 and measured on a the closest timepoint prior to pancreatoduodenectomy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
The additional value of prolonged antibiotics after pancreatic head surgery to reduce the rate of postoperative infectionsPancreatic head malignancyMedDRA version: 21.0Level: LLTClassification code 10033614Term: Pancreatic carcinoma resectableSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: LLTClassification code 10026319Term: Malignant neoplasm of pancreatic ductSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 27.0Level: LLTClassification code 10008597Term: Cholangiocarcinoma resectableSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2022-003217-11-NLeiden University Medical Center304
Recruiting
Not Applicable
Standard versus Pre-emptive Antibiotic Treatment to Reduce the Rate of Infectious Outcomes after Whipple procedure (SPARROW): a multicenter, randomized controlled trialPancreatic cancer100179901001981510014713
NL-OMON56173eids Universitair Medisch Centrum344
Not yet recruiting
Not Applicable
Comparison of one day with four days antibiotic use in cancer patients
CTRI/2018/06/014344Basavatarakam IndoAmerican Cancer Hospital and Research Institute
Completed
Not Applicable
on-antibiotic versus Antibiotic Prophylaxis for Recurrent Urinary Tract Infections
ISRCTN50717094Academic Medical Centre (AMC) (The Netherlands)560
Recruiting
Phase 4
Routine Antibiotic vs. Directed Antibiotic Treatment in Snake BiteHealth Condition 1: null- Snake bites
CTRI/2017/03/007975Jawaharlal Institute of Postgraduate Medical Education and Research130